Food Intervention to Reduce Immunotherapy ToXicity
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversitair Ziekenhuis Brussel
About this trial
The FORX (Food intervention to Reduce immunotherapy toXicity) trial will assess whether supplementing dietary fiber intake by providing weekly boxes containing 30 different plants to patients with solid tumors starting immune checkpoint inhibitor therapy affects the incidence of immune related adverse events.
Eligibility criteria
Qualifiers
solid tumor starting anti-programmed cell death protein 1 (anti-PD1) and/or anti-cytotoxic T-lymphocyte-associated antigen 4 (anti-CTLA4) antibodies as part of standard of care.
able to sign informed consent.
Disqualifiers
no oral intake possible.
probiotic use and unwillingness to stop during the trial.
combination therapy with chemotherapy or targeted agents.
Trial design
Treatments tested in this trial
- Food box containing 30 different plants
Treatment groups
60 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov